Supriya Lifescience soars after Q4 PAT jumps 47.4% YoY
Mumbai, May 29 -- The company's consolidated net profit rose 47.4% YoY and 49.4% QoQ to Rs 74.23 crore in Q4 FY26. Revenue from operations jumped 50.2% YoY and 34% QoQ to Rs 276.53 crore in the March 2026 quarter.
EBITDA stood at Rs 97.62 crore in Q4 FY26, up 44.4% vs Q4 FY25 and 35.4% vs Q3 FY26. EBITDA margin came in at 35.3% compared with 36.7% in Q4 FY25 and 34.9% in Q3 FY26.
PBT stood at Rs 92.13 crore in Q4 FY26, up 37.7% vs Q3 and 43.8% vs Q4 FY25.
On the cost front, cost of goods sold surged 92.1% YoY to Rs 105.33 crore. Employee benefit expenses increased 18.3% to Rs 24.82 crore, while other expenses rose 19.8% to Rs 48.77 crore. Finance costs stood at Rs 0.47 crore, up 12.1% YoY, and depreciation and amortisation expenses inc...
Click here to read full article from source
इस लेख के रीप्रिंट को खरीदने या इस प्रकाशन का पूरा फ़ीड प्राप्त करने के लिए, कृपया
हमे संपर्क करें.